|
Charles Warden has been an active medical device investor since 1992. Prior to joining Versant he was a general partner at Schroder Ventures Life Sciences (now SV Life Sciences) where he led SV’s medical device effort. Previously, Charles worked with Boston Capital Ventures, where he concentrated on medical device and other healthcare investments. Before becoming a venture capitalist, Charles was a consultant with Monitor Company, a strategy consulting firm. Charles has served on numerous medical device company boards, including the following currently: AcuFocus, Celula, Concentric Medical, Glumetrics, Halsicon, iTherapeutix, LipoSonix and WaveTec. While at SV he was a board member of various companies including Insulet (Nasdaq: PODD), Confluent Surgical (acquired by Tyco), CardioFocus, Neovista, Sadra Medical, and Heritage Health Systems (acquired by Universal American Financial Corp). Since its inception, Charles has been actively involved with The Innovation Factory, a medical devices incubator. He is also involved in ForSight Labs, an ophthalmic incubator. Charles holds a Bachelor’s degree from Beloit College and an MBA from Harvard Business School. | 